This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Contact Us | Sign In | Register
2019 Summer Meeting Agenda

45th Annual Summer Meeting—Detailed Agenda 

Program Planning Committee Members

   

Jamie DeWitt, East Carolina University (Chair)
Brian Hughes, NSF International (Co-Chair)
Joanne Birkebak, Gilead
Sarah Blossom, University of Arkansas for Medical Sciences
Grace Chappell, ToxStrategies, Inc.
Laurie Dolan, US FDA/CFSAN
Jeanne Domoradzki, Corteva Agriscience
Maia Green, ExxonMobil Biomedical Sciences, Inc.
Barry McIntyre, NIEHS-NTP
Edward Ohanian, US EPA/OW (Board Liaison)
Santhini Ramasamy, US EPA/NCEA
Amy Roe, Procter & Gamble Company

 

Detailed Program Schedule By Day

 

 

Monday, July 8

 

8:00 AM–10:00 AM

SESSION: Communicating Complex Toxicological Science to Diverse Audiences

Moderator: Katlyn May, Center for Human Health and the Environment at North Carolina State University

8:00 AM–8:20 AM

Creating a Dialogue to Educate Legislators about Timely Scientific Problems: A State Perspective

Jeff Warren, North Carolina Policy Collaboratory

8:20 AM–8:40 AM

Chemical Hazards on Military Bases: Communicating Laboratory Science to Potentially Exposed Military Personnel

Sarah Blossom, Arkansas Children's Research Institute

8:40 AM–9:00 AM

Inspiring the Public to Learn about Toxicology: How the Voice of Journalism Is a Tool for Public Health Education

Vaughn Hagerty, Freelance Journalist

9:00 AM–9:20 AM

Communicating and Translating the US EPA’s Science to Diverse Stakeholder Groups from the Scientific Community to the General Public

Monica Linnenbrink, US EPA/NCCT

9:20 AM–10:00 AM

Moderated Panel and Attendee Discussion

 

10:00 AM–10:30 AM

Scientific Program Break—Attendee Small Group Discussion

10:30 AM–12:30 PM

SESSION: Should Fluoropolymers, Polymeric PFAS Meeting OECD Polymer of Low-Concern (PLC) Criteria, Be Grouped with All PFAS for Regulatory Purposes?

Moderated by Barbara Henry, W.L. Gore & Associates

10:30 AM–10:55 AM

What Differentiates Polymers from Non-polymers and Fluoropolymers from Other Polymers? 

Sina Ebnesajjad, FluoroConsultants Group, LLC

10:55 AM–11:20 AM

Why Data Packages for Polymers and Non-polymers Differ and Are Not “Data Gaps” 

Margaret Whittaker, ToxServices, LLC

11:20 AM–11:45 AM

What Are the Appropriate Physiochemical Properties to Identify Polymers of Concern (PoC)?  

Jeffrey Hafer, knoell USA

 

11:45 AM–12:10 PM

Fluoropolymers Are the Exceptional PFAS Class, Distinctly Different from the Other Four PFAS Classes and Should Be Excluded from Grouping of PFAS Classes for Management Actions  

Barbara Henry, W.L. Gore & Associates

12:10 PM–12:30 PM

Moderated Panel and Attendee Discussion

 

12:30 PM–1:30 PM

Attendee Luncheon
(Included with Registration)

1:30 PM–5:00 PM

SESSION: Threshold-Based Cancer Risk Assessment for Carcinogens: Inorganic Arsenic as a Case Study

Moderator: Samuel Cohen, University of Nebraska Medical Center

1:30 PM–2:00 PM

Mode-of-Action for Inorganic Arsenic-Induced Cancer and Evaluation of Animal Studies

Samuel Cohen, University of Nebraska Medical Center

2:00 PM–2:30 PM

In Vitro Investigations of Inorganic Arsenic and Calculation of Estimated Threshold in Humans Based on Non-epidemiology Data

Harvey Clewell, Ramboll US Corp

2:30 PM–3:00 PM

Epidemiology of Cancer and Inorganic Arsenic in Drinking Water and the Basis for Estimated Threshold of 100 µg/L

Ellen Chang, Exponent, Inc

3:00 PM–3:30 PM

Scientific Program Break—Attendee Small Group Discussion

3:30 PM–4:00 PM

Implications of the Threshold Approach for Food Safety Evaluation

Rosalind Schoof, Ramboll US Corp

4:00 PM–4:30 PM

Implications of the Threshold Approach for Environmental Risk Assessment for Inorganic Arsenic in the Drinking Water

Sabine Lange, Texas Commission on Environmental Quality

4:30 PM–5:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Evisabel Craig, US EPA/OPP

5:45 PM–7:00 PM Welcome Reception

 

Tuesday, July 9

 

8:00 AM–11:30 AM

SESSION: Are US vs. EU Differences in Regulatory Framework for Developmental Thyroid and Neurotoxicity Testing Triggering Unnecessary Testing and Labeling?

Speaker Question Moderators: Jeanne Domoradzki, Corteva Agriscience; and Abby Li, Exponent, Inc.

Panel Discussion Moderators: Elizabeth Mendez, US EPA/OPP; and Simon Warren, UK Office, Exponent International Limited

8:00 AM–8:20 AM

US and EU Regulatory Conundrums and Technical Challenges

Abby Li, Exponent, Inc.

Industry Survey

Jeanne Domoradzki, Corteva Agriscience

8:20 AM–8:45 AM

The EU E(ndocrine)-Factor Impact on Developmental Thyroid (DTT) and Related (Neuro)toxicity Testing, Hazard Assessment, and Labeling

Simon Warren, UK Office, Exponent International Limited

8:45 AM–9:15 AM

Thyroid Hormone Triggers: Why DTT and Not DNT?

Mary Gilbert, US EPA/NHEERL

9:15 AM–9:45 AM

Are All Thyroid Hormone Changes Adverse? Case for Consideration of DNT to Interpret DTT—Regulatory Issues

Sue Marty, Dow Chemical Company, US

9:45 AM–10:15 AM

Tales from the Trenches: Implementing New ECHA/EFSA Guidance on Mode-of-Action of Thyroid-Disruption and on the Weight of Evidence for Human Relevance

Remi Bars, Bayer SAS, France

10:15 AM–10:45 AM Scientific Program Break—Attendee Small Group Discussion
10:45 AM–11:30 AM

Moderated Panel and Attendee Discussion

Includes all invited speakers

11:30 AM–12:00 Noon

George H. Scott Memorial Award Lecture

Awardee: Susan Felter, Procter & Gamble Company

12:00 Noon–12:30 PM

Toxicology Forum Annual Business Meeting

All Attendees Welcome

12:30 PM–1:30 PM Attendee Luncheon
(Included with registration)
1:30 PM–2:00 PM

UPDATE PRESENTATION: Per- and Poly-fluoroalkyl Substances (PFAS): A Lifecycle Perspective

Jamie DeWitt, East Carolina University, Brody School of Medicine

This presentation is supported through the David Miller Award Funds.

2:00 PM–2:30 PM

UPDATE PRESENTATION: The Key Characteristics of Carcinogens Concept Is Now Incorporated into the International Agency for Cancer Research’s (IARC) Preamble: Implications

Jay Goodman, Michigan State University

This presentation is supported through the David Miller Award Funds.

2:30 PM–5:00 PM

The Gut Microbiome: Impact on Metabolism of Drugs, Dietary Contaminants and Health

Moderator: Cody Wilson, The Coca-Cola Company

This session is supported through the David Miller Award Funds.

2:30 PM–3:00 PM

The Myriad Interactions of Drugs with Gut Bacterial Beta-Glucuronidases

Sam Pellock, University of North Carolina at Chapel Hill

3:00 PM–3:30 PM Scientific Program Break—Attendee Small Group Discussion
3:30 PM–4:00 PM

Dietary Exposures: Role of the Microbiome in Influencing the Effect of Environmental Compounds on Gut Health

Clint Allred, Texas A&M University

4:00 PM–4:30 PM

Observations and Challenges in Deciphering Study to Study Results of Microbiome Analysis in Toxicological Risk Assessment of Xenobiotic Residues in Food

Carl Cerniglia, US FDA/NCTR

4:30 PM–5:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Paul Carlson, US FDA/CBER

6:00 PM–7:00 PM Attendee Reception
(Included with Registration) 

 

Wednesday, July 10

 

8:00 AM–10:00 AM

SESSION: Collaboration Is Key: Predictive Computational Models for Acute Systemic Toxicity

Moderated by Esther Haugabrooks, Physician's Council for Responsible Medicine

8:00 AM–8:30 AM

Implementation of Nonanimal Approaches for Acute Systemic Toxicity

Grace Patlewicz, US EPA/NCCT

8:30 AM–9:00 AM

Collaborative Computational Efforts to Predict Acute Oral Toxicity 

Kamel Mansouri, ILS

9:00 AM–9:30 AM

A Cross-Industry Effort to Develop Protocols for In Silico Approaches for Acute Dose Toxicity: The Food Safety Perspective

Elena Lo Piparo, Nestle

9:30 AM–10:00 AM

Moderated Panel and Attendee Discussion

 

10:00 AM–10:30 AM Scientific Program Break—Attendee Small Group Discussion
10:30 AM–2:00 PM

SESSION: Build the Confidence to Protect Human Health without the Cancer Bioassay

Moderated by June Yan, Corteva Agriscience

10:30 AM–11:00 AM

Alternatives for Rodent Carcinogenicity Study: Pharmaceutical Perspectives

Frank Sistare, Merck & Co., Inc.

11:00 AM–11:30 AM

The Two-Year Bioassay Is No Longer Necessary: Liver and Urinary Bladder as Examples

Samuel Cohen, University of Nebraska Medical Center

11:30 AM–12:00 Noon

Utilizing Gene Set Enrichment Analysis to Analyze Toxicogenomic Data for Use in Human Health Risk Assessment

Jeffrey Dean, US EPA/NCEA

12:00 Noon–12:30 PM Scientific Program Break—Attendee Small Group Discussion
12:30 PM–1:00 PM

Alternative Methods for Cosmetics Testing: Personal Care Industry

Susan Felter, Procter & Gamble Company

1:00 PM–1:30 PM

The Future of Agrochemical Risk Assessment: Framework for Conducting Chronic Risk Assessment with Enhanced Short-Term Toxicological Studies and Significantly Reduced Residue Trial Studies

June Yan, Corteva Agriscience

1:30 PM–2:00 PM

Moderated Panel and Attendee Discussion

All speakers with additional panelist;
Todd Bourcier, US FDA/CDER